Evidence map›Paper›PMID 40314353›Full record

SynthesisJournal of the American Heart Association2025

High Burden and Trend in Nonadherence to Blood Pressure-Lowering Medications: Meta-Analysis of Data From Over 34 000 Adults With Hypertension in Sub-Saharan Africa.

Leopold N Aminde, Valirie N Agbor, Noah T Fongwen, Calypse A Ngwasiri, Clovis Nkoke, Miriam A Nji, Anastase Dzudie, Aletta E Schutte

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Overcoming variable response in renal denervation: Key strategies for reliable clinical implementation.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Leopold N AmindePublic Health & Economics Modelling Group, School of Medicine and Dentistry Griffith University Gold Coast Australia.ORCID 0000-0003-2787-7518
Valirie N AgborClinical Trials Service and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health University of Oxford UK.ORCID 0000-0002-6708-6852
Noah T FongwenMinistry of Public Health Yaounde Cameroon.
Calypse A NgwasiriNon-Communicable Diseases Unit Clinical Research Education, Networking & Consultancy (CRENC) Douala Cameroon.
Clovis NkokeFaculty of Health Sciences University of Buea Cameroon.ORCID 0000-0002-2617-6712
Miriam A NjiNortheast Georgia Medical Center Braselton GA USA.ORCID 0000-0003-0208-0211
Anastase DzudieNon-Communicable Diseases Unit Clinical Research Education, Networking & Consultancy (CRENC) Douala Cameroon.ORCID 0000-0003-4038-4128
Aletta E SchutteSchool of Population Health University of New South Wales Sydney Australia.ORCID 0000-0001-9217-4937

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNonadherence to blood pressure (BP)-lowering medication is a strong predictor of poor BP control. Sub-Saharan Africa has extremely low BP control rates (~10%), but it is unclear what the burden of medication nonadherence among Africans with hypertension is. This systematic review estimated the prevalence and determinants of nonadherence to BP-lowering medications in Sub-Saharan Africa. METHODS AND

resultsMultiple databases were searched from inception to December 6, 2023. Two reviewers performed independent screening, extraction, and quality assessment of studies. We pooled the prevalence estimates using random effects meta-analyses and summarized the determinants using a narrative synthesis. From the 1307 records identified, we included 95 studies published between 1995 and 2023. The overall prevalence of nonadherence to BP-lowering medication among 34 102 people treated for hypertension in 27 countries was 43.9% (95% CI, 39.2-48.6). There was no change in the prevalence of nonadherence over time. Nonadherence varied by measurement method and by median age (39.4%, ≥57 years versus 47.9%, <57 years). Socioeconomic and patient-related factors were the most frequent factors influencing adherence. Active patient participation in management, accurate perceptions, and knowledge of hypertension and its treatment predicted good medication adherence, whereas high pill burden, medication cost, side effects, and comorbidities predicted poor adherence.

conclusionsTwo out of every 5 people are nonadherent to their BP treatment. With the African population projected to increase from 1.4 to ~2.5 billion by 2050, targeted strategies are urgently needed to optimize medication adherence in people with hypertension in Sub-Saharan Africa.

Indexed as

Antihypertensive AgentsBlood PressureHypertensionMedication AdherenceAdultAfrica South of the SaharaFemaleHumansMaleMiddle AgedPrevalenceAntihypertensive AgentsAfricadeterminantshypertensionmedication adherencesystematic review

Identifiers

PMID40314353
PMCPMC12184231

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.